Synvolux manufactures and markets products for highly efficient, non-viral delivery of macromolecules, such as DNA, RNA, and protein/peptides. Its proprietary technology (SAINT™) is used worldwide under various brand names and is based on synthetic cationic lipids with proven safety and broad applicability both in vitro and in vivo. Synvolux welcomes partners interested in using SAINT™ lipids for various therapeutic applications.
Company Details
- Employees
- 2
- Founded
- -
- Address
- J.h. Oortweg 19-21, Leiden,zh 2333 Ch,netherlands
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- saintnl.com
- Keywords
- Custom products, In-house manufacturing, DNA transfection, RNA transfection, Protein/peptide transfection, GMP support.
- HQ
- Leiden, ZH
Synvolux Products & Therapeutics B.v. Questions
Synvolux Products & Therapeutics B.V.'s website is saintnl.com
Synvolux Products & Therapeutics B.V.'s LinkedIn profile is https://nl.linkedin.com/company/synvolux
Synvolux Products & Therapeutics B.V. has
2 employees.
View email and phone details for 2
employees at Synvolux Products & Therapeutics B.V..
Synvolux Products & Therapeutics B.V.'s industry is
Biotechnology Research
Synvolux Products & Therapeutics B.V.'s top competitors are
Charles River Laboratories,
Isa Pharmaceuticals,
Navera,
Stichting Etb-Bislife,
Proqr Therapeutics,
Seranovo,
Celid Biotechnologies Inc.,
Medcell Pharma,
Dynegene Technologies,
Cosimi Bio.
Synvolux Products & Therapeutics B.V.'s categories are Biotechnology Research
Synvolux Products & Therapeutics B.V.'s founding year is 2002
